Vaisala Group
Vaisala Corporation: Share Repurchase 29.8.2025
Vaisala Corporation: Share Repurchase 29.8.2025
| VAISALA CORPORATION | STOCK EXCHANGE RELEASE 29.8.2025 | |
| Vaisala Corporation: Share Repurchase 29.8.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 29.8.2025 | |
| Bourse trade | Buy | |
| Share | VAIAS | |
| Amount | 3 000 | Shares |
| Average price/ share | 46,2000 | EUR |
| Total cost | 138 600,00 | EUR |
| Vaisala Corporation now holds a total of 157 300 shares | ||
| including the shares repurchased on 29.8.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Vaisala Corporation | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
More information:
Niina Ala-Luopa
+358 400 728 957, ir@vaisala.com
Distribution:
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. www.vaisala.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VCI Global Limited4.9.2025 21:30:00 CEST | Press release
VCI Global’s Fintech Arm Credilab Achieves US$35 Million Loan Book with 53% Revenue Growth; Secures Conditional Approval for Full Online Lending License
Rapafusyn Pharmaceuticals4.9.2025 20:24:11 CEST | Press release
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
Avania4.9.2025 19:35:16 CEST | Press release
Avania Strengthens Leadership Team with Appointment of Four New Executives
Vaisala Group4.9.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 4.9.2025
LambdaTest, Inc.4.9.2025 17:00:00 CEST | Press release
Boomi Achieves 78% Faster Testing Cycles Using LambdaTest’s HyperExecute Platform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom